Effect of Pentoxifylline on Microalbuminuria in Diabetic Patients: A Randomized Controlled Trial

Table 1

Baseline characteristics in 40 studies patients by groups.

	Case group ()	Control group ()	value
Age (year)	50.3 ± 9	55.6 ± 10.7	0.1^*
Sex
Male	9 (40.9)	6 (33.3)	0.8^†
Female	13 (59.1)	12 (66.7)
Weight (kg)	79.60 ± 2.40	78.45 ± 1.68	0.86^*
Body mass index	30.51 ± 7.13	30.75 ± 4.22	0.90^*
GFR (mL/min/1.73 m^2)	73.93 ± 1.05	71.54 ± 9.29	0.45^*
HbA1C (%)	7.76 ± 1.62	7.4 ± 1.6	0.55^*
Duration of being diabetic	5.95 ± 5.58	5.54 ± 5.87	0.82^*

Data expressed as mean ± SD or number (percent). GFR: glomerular filtration rate; HbA1C: glycosylated hemoglobin.
Case group included 20 patients who received regular medications plus 400 mg pentoxifylline. Control group included 20 patients who received regular medications plus placebo.
values calculated by ^*Independent Samples Test, ^†Chi-square test.